The lowering of blood pressure after stroke

Comment

A Fournier et al. Lancet. 2001.

. 2001 Dec 8;358(9297):1995-6.

doi: 10.1016/S0140-6736(01)06983-5.

No abstract available

Comment on

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE. Hansson L, et al. Lancet. 1999 Feb 20;353(9153):611-6. doi: 10.1016/s0140-6736(98)05012-0. Lancet. 1999. PMID: 10030325 Clinical Trial.
Blood-pressure lowering for the secondary prevention of stroke.
Staessen JA, Wang J. Staessen JA, et al. Lancet. 2001 Sep 29;358(9287):1026-7. doi: 10.1016/S0140-6736(01)06226-2. Lancet. 2001. PMID: 11589927 No abstract available.